Hinge Health (HNGE) Insider Group Buys 112,477 Shares

On June 23, 2026, LLC Insight Holdings Group bought 112,477 shares of Hinge Health, Inc. (NYSE: HNGE). This purchase highlights the group's continued interest in Hinge Health, as the stock traded around $70.38 on Thursday.

What Changed in LLC Insight Holdings Group's Hinge Health Position

LLC Insight Holdings Group increased its stake in Hinge Health by buying 112,477 shares. This transaction marks a significant move in the group's investment strategy, though the exact reason for the purchase wasn't disclosed. The shares were bought without a pre-planned transaction, signifying a direct decision to increase their holding.

Other Institutional Activity in Hinge Health

Other institutional investors have also been active in Hinge Health. Insight Holdings Group, LLC maintained its holdings with 9,375,164 shares, valued at approximately $361.5 million. 11.2 Capital Management, LLC also kept its position steady with 3,704,524 shares worth about $142.8 million. Deer Management Co. LLC opened a new position, acquiring 2,633,707 shares valued at $101.6 million. On the other hand, Bit Capital GmbH reduced its stake by 1,006,304 shares, ending with 2,309,797 shares, a 30.3% decrease. Meanwhile, RTW Investments, LP significantly increased its holdings by 1,576,500 shares, totaling 1,930,000 shares, a 446% increase.

Hinge Health, Inc. Stock Down 32.8%

Shares of Hinge Health, Inc. (NYSE: HNGE) traded near $70.38 on Thursday. The company has a market cap of approximately $5.33 billion and a forward P/E ratio of 20.59. Its stock has a 52-week low of $30.08 and a high of $71.43. The 50-day moving average is $52.90, and the 200-day moving average is $47.85. Hinge Health maintains a current ratio of 1.30 and a quick ratio of 1.04, with a debt-to-equity ratio of 2.24.

Recent Earnings

Hinge Health reported revenue of $646.3 million, showing a growth of 47.2%. However, the company recorded a net margin of -78.95% and a return on equity of -136.0%. The next earnings report is expected on August 4, 2026.

Insider Buying and Selling at Hinge Health, Inc.

On June 23, 2026, LLC Insight Holdings Group bought 112,477 shares of Hinge Health. The transactions were not planned under Rule 10b5-1, indicating a direct decision to buy. The following day, June 24, the same entity sold 533,228 shares at an average price of $71.29, but this sale was planned.

Analysts Set New Price Targets

On June 24, 2026, Wells Fargo maintained its buy rating on Hinge Health with a price target of $90. Other firms like Baird and Raymond James also maintained their ratings, with Baird holding at $65 and Raymond James at $80. The consensus among 15 analysts is a buy rating, with an average target price of $79.73.

About Hinge Health, Inc.

Hinge Health, Inc. is a healthcare company based in San Francisco, California, specializing in musculoskeletal care. Founded in 2012, the company uses technology to deliver scalable and automated care solutions. Its platform addresses issues like acute injury, chronic pain, and post-surgical rehabilitation, using AI-powered motion tracking and proprietary wearable devices. Hinge Health primarily serves self-insured employers and is led by CEO Daniel A. Perez.

Bottom Line

LLC Insight Holdings Group's recent purchase of Hinge Health shares underscores its ongoing interest in the company. Hinge Health's stock has shown strong performance, with analysts maintaining positive outlooks. The company's focus on innovative healthcare solutions continues to attract institutional attention.